Skip to main content
. Author manuscript; available in PMC: 2012 Aug 15.
Published in final edited form as: Mov Disord. 2011 May 5;26(10):1913–1921. doi: 10.1002/mds.23731

Table 1.

Clinical patient data

patient gender age (decade) duration (years) DYT1-status distribution medication DBS setting (all monopolar) electrode position
1 w 4 28 + generalized none L:0- and 1-,3.5V,60μsec,130Hz;
R:4- and 5-,3.5V,60μsec,130Hz
L: GPi
R: GPi
2 w 5 20 neck, L+R UL, trunk, L+R LL Benzhexol L:0-,3.5V,120μsec,130Hz;
R:4-,3.5V,120μsec,130Hz
L: GPi
R: GPi
3 w 3 16 generalized Benzhexol L:0-,3.1V,60μsec,130Hz;
R:5-,2.6V,90μsec,130Hz
L: GPi
R: GPi
4 w 6 21 face, neck, L prox. UL, trunk none L:1-,3.2V,60μsec,130Hz;
R:5-,3.2V,60μsec,130Hz
L: GPi
R: GPi
5 w 5 35 face, neck, trunk Benzhexol L:0-,3.6V,60μsec,130Hz;
R:4-,3.6V,60μsec,130Hz
L: GPi
R: GPi
6 m 5 20 face, neck, trunk, R UL none L:0- and 1-, 1.8V, 60μsec,130Hz;
R:4-,2.9V,60μsec,130Hz
L: GPi
R: GPi
7 w 7 20 neck none L:0-,2.2V,60μsec,130Hz;
R:4-,2.2V,60μsec,130Hz
L: GPi
R: GPi
8 m 4 8 neck Citalopram L:1-,2.6V,60μsec,130Hz;
R:5-,2.6V,60μsec,130Hz
L: GPi
R: GPi

LL=lower limb, UL=upper limb